Acamprosate
- Generic Name
- Acamprosate
- Brand Names
- Campral
- Drug Type
- Small Molecule
- Chemical Formula
- C5H11NO4S
- CAS Number
- 77337-76-9
- Unique Ingredient Identifier
- N4K14YGM3J
- Background
Alcohol use disorder is responsible for a large worldwide burden of morbidity, premature mortality, and economic consequences resulting from accidents, violence, incarceration, decreased productivity, and increased healthcare spending.
...
- Indication
Acamprosate is indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. It is also indicated for the maintenance of alcohol abstinence in patients who have undergone alcohol detoxification. This drug should be used with a psychosocial support program providing adequate support.
- Associated Conditions
- Alcohol Abstinence, Alcohol Dependency
- Associated Therapies
- -
Study of Acamprosate to Prevent Alcohol Relapse in Criminal Justice Supervisees
- First Posted Date
- 2005-11-07
- Last Posted Date
- 2016-05-11
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 26
- Registration Number
- NCT00249379
- Locations
- 🇺🇸
Virginia Commonwealth University Medical Center, Richmond, Virginia, United States
Integrative Therapy in Alcoholism
- Conditions
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-01-30
- Lead Sponsor
- Heinrich-Heine University, Duesseldorf
- Target Recruit Count
- 371
- Registration Number
- NCT00159107
- Locations
- 🇩🇪
Department of Psychiatry and Psychotherapy at the Heinrich-Heine-University Düsseldorf, Rhineland State Clinics Düsseldorf, Bergische Landstraße 2, 40629 Düsseldorf, Germany, Düsseldorf, North Rhine-Westfalia, Germany
Trial for the Treatment of Alcohol Dependence
- Conditions
- First Posted Date
- 2005-07-18
- Last Posted Date
- 2005-07-18
- Lead Sponsor
- University of Sydney
- Target Recruit Count
- 200
- Registration Number
- NCT00120601
- Locations
- 🇦🇺
Drug Health Services, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.